VistaGen Therapeutics, Inc.
VTGN
$0.24
-$0.01-3.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.68% | -19.35% | -34.14% | -49.81% | -40.64% |
| Total Depreciation and Amortization | 16.57% | 14.46% | 17.39% | 17.83% | 11.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.56% | -9.34% | -2.56% | -2.26% | -30.41% |
| Change in Net Operating Assets | 41.96% | -133.94% | -95.28% | 378.12% | -230.11% |
| Cash from Operations | 21.96% | -61.00% | -71.51% | -26.39% | -73.39% |
| Capital Expenditure | -- | 100.00% | -- | 1.64% | -54.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -116.10% | 130.81% | 99.56% | 86.67% |
| Cash from Investing | 100.00% | -118.79% | 124.64% | 98.79% | 85.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.67% | -- | -- | -- | -- |
| Issuance of Common Stock | 80.11% | -100.00% | 104.10% | -- | 534.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -38.91% | -114.51% | 80.36% | -- | 1,590.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.96% | -118.64% | -61.74% | 173.91% | -11.68% |